Proteomic analysis of protein expression in prostate cancer

Analytical and Quantitative Cytology and Histology

Volumn 27, Issue 5, 2005, Pages 263-272

  Lexander, Helena ^a   Palmberg, Carina ^a   Auer, Gert ^a   Hellström, Magnus ^b   Franzén, Bo ^c   Jörnvall, Hans ^a   Egevad, Lars ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c ASTRAZENECA R AND D   (Sweden)

Author keywords

Electrophoresis, gel, two dimensional; Prostate cancer; Proteomics

Indexed keywords

ACYL COENZYME A DEHYDROGENASE; CHROMOBOX PROTEIN; CYTOKERATIN; CYTOSOL AMINOPEPTIDASE; ENDOPEPTIDASE CLP; GLUCOSE REGULATED PROTEIN 78; HEAT SHOCK PROTEIN 60; HEAT SHOCK PROTEIN 70; INORGANIC PYROPHOSPHATASE; ISOCITRATE DEHYDROGENASE; MEMBRANE PROTEIN; NUCLEOSIDE DIPHOSPHATE KINASE; NUCLEOSIDE DIPHOSPHATE KINASE 1; PROTEIN; PROTEIN DISULFIDE ISOMERASE; PROTEIN L 12; PYRUVATE DEHYDROGENASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); RIBOSOME PROTEIN; STOMATIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENERGY METABOLISM; GENE SILENCING; HUMAN; HUMAN CELL; MALE; MASS SPECTROMETRY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROSTATECTOMY; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; PROTEOMICS; QUANTITATIVE ANALYSIS; SEQUENCE ANALYSIS; TANDEM MASS SPECTROMETRY; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; PROSTATIC NEOPLASMS; PROTEOMICS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 27144449311     PISSN: 08846812     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Hsing AW, Tsao L, Devesa SS: International trends and patterns of prostate cancer incidence and mortality. Int J Cancer 2000;85:60-67
2. Holmberg L, Bill-Axelson A, Helgesen F, Salo JO, Folmerz P, Haggman M, Andersson SO, Spangberg A, Busch C, Nordling S, Palmgren J, Adami HO, Johansson JE, Norlen BJ: A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer. N Engl J Med 2002; 347:781-789
3. Singh D, Febbo PG, Ross K, Jackson DG, Manola J, Ladd C, Tamayo P, Renshaw AA, D'Amico AV, Richie JP, Lander ES, Loda M, Kantoff PW, Golub TR, Sellers WR: Gene expression correlates of clinical prostate cancer behavior. Cancer Cell 2002;1:203-209
4. Adam BL, Qu Y, Davis JW, Ward MD, Clements MA, Cazares LH, Semmes OJ, Schellhammer PF, Yasui Y, Feng Z, Wright GL Jr: Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men. Cancer Res 2002;62:3609-3614
5. Lexander H, Franzén B, Hirschberg D, Becker S, Hellström M, Bergman T, Jörnvall H, Auer G, Egevad L: Differential protein expression in anatomical zones of the prostate. Proteomics 2005;5:2570-2576
6. Franzen B, Linder S, Okuzawa K, Kato H, Auer G: Nonenzymatic extraction of cells from clinical tumor material for analysis of gene expression by two-dimensional polyacrylamide gel electrophoresis. Electrophoresis 1993;14: 1045-1053
7. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-254
8. Bjellqvist B, Ek K, Righetti PG, Gianazza E, Gorg A, Westermeier R, Postel W: Isoelectric focusing in immobilized pH gradients: Principle, methodology and some applications. J Biochem Biophys Methods 1982;6:317-339
9. Sanchez JC, Hochstrasser D, Rabilloud T: In-gel sample rehydration of immobilized pH gradient. Methods Mol Biol 1999;112:221-225
10. Rabilloud T, Vuillard L, Gilly C, Lawrence JJ: Silver-staining of proteins in polyacrylamide gels: A general overview. Cell Mol Biol 1994;40:57-75
11. Garrels JI: The QUEST system for quantitative analysis of two-dimensional gels. J Biol Chem 1989;264:5269-5282
12. Gustafsson M, Hirschberg D, Palmberg C, Jornvall H, Bergman T: Integrated sample preparation and MALDI mass spectrometry on a microfluidic compact disk. Anal Chem 2004;76:345-350
13. Dhanasekaran SM, Barrette TR, Ghosh D, Shah R, Varambally S, Kurachi K, Pienta KJ, Rubin MA, Chinnaiyan AM: Delineation of prognostic biomarkers in prostate cancer. Nature 2001;412:822-826
14. Luo J, Duggan DJ, Chen Y, Sauvageot J, Ewing CM, Bittner ML, Trent JM, Isaacs WB: Human prostate cancer and benign prostatic hyperplasia: Molecular dissection by gene expression profiling. Cancer Res 2001;61:4683-4688
15. Liu AY, Zhang H, Sorensen CM, Diamond DL: Analysis of prostate cancer by proteomics using tissue specimens. J Urol 2005;173:73-78
16. Zheng Y, Xu Y, Ye B, Lei J, Weinstein MH, O'Leary MP, Rlchie JP, Mok SC, Liu BC: Prostate carcinoma tissue proteomics for biomarker discovery. Cancer 2003;98:2576-2582
17. Gretzer MB, Chan DW, van Rootselaar CL, Rosenzweig JM, Dalrymple S, Mangold LA, Partin AW, Veltri RW: Proteomic analysis of dunning prostate cancer cell lines with variable metastatic potential using SELDI-TOF. Prostate 2004;60:325-331
18. Li J, White N, Zhang Z, Rosenzweig J, Mangold LA, Partin AW, Chan DW: Detection of prostate cancer using serum proteomics pattern in a histologically confirmed population. J Urol 2004;171:1782-1787
19. Alaiya AA, Oppermann M, Langridge J, Roblick U, Egevad L, Brindstedt S, Hellstrom M, Linder S, Bergman T, Jornvall H, Auer G: Identification of proteins in human prostate tumor material by two-dimensional gel electrophoresis and mass spectrometry. Cell Mol Life Sci 2001;58:307-311
20. Alaiya A, Roblick U, Egevad L, Carlsson A, Franzen B, Volz D, Huwendiek S, Linder S, Auer G: Polypeptide expression in prostate hyperplasia and prostate adenocarcinoma. Anal Cell Pathol 2000;21:1-9
21. Meehan KL, Holland JW, Dawkins HJ: Proteomic analysis of normal and malignant prostate tissue to identify novel proteins lost in cancer. Prostate 2002;50:54-63
22. McNeal JE, Redwine EA, Freiha FS, Stamey TA: Zonal distribution of prostatic adenocarcinoma: Correlation with histologic pattern and direction of spread. Am J Surg Pathol 1988;12:897-906
23. Eble JN, Sauter G, Epstein JI, Sesterhenn IA: Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs. Lyon, IARC Press, 2004
24. Epstein JI, Partin AW, Sauvageot J, Walsh PC: Prediction of progression following radical prostatectomy: A multivariate analysis of 721 men with long-term follow-up. Am J Surg Pathol 1996;20:286-292
25. Green GA, Hanlon AL, Al-Saleem T, Hanks GE: A Gleason score of 7 predicts a worse outcome for prostate carcinoma patients treated with radiotherapy. Cancer 1998;83:971-976
26. Egevad L, Granfors T, Karlberg L, Bergh A, Stattin P: Prognostic value of the Gleason score in prostate cancer. BJU Int 2002;89:538-542
27. Rubin MA, Dunn R, Kambham N, Misick CP, O'Toole KM: Should a Gleason score be assigned to a minute focus of carcinoma on prostate biopsy? Am J Surg Pathol 2000;24:1634-1640
28. Hermanek P, Hutter RVP, Sobin LH, Wagner G, Wittekind C: TNM Atlas: Illustrated Guide to the TNM/pTNM Classification of Malignant Tumours. Sixth edition. Berlin, Springer, 2002
29. Jensen SL, Wood DP Jr, Banks ER, Veron M, Lascu I, McRoberts JW, Rangnekar VM: Increased levels of nm23 H1/nucleoside diphosphate kinase A mRNA associated with adenocarcinoma of the prostate. World J Urol (suppl 1) 1996;14: S21-S25
30. Jones DO, Mattei MG, Horsley D, Cowell IG, Singh PB: The gene and pseudogenes of Cbx3/mHP1 gamma. DNA Seq 2001;12:147-160
31. Wahl MC, Moller W: Structure and function of the acidic ribosomal stalk proteins. Curr Protein Pept Sci 2002;3:93-106
32. Rapoport TA, Matlack KE, Plath K, Misselwitz B, Staeck O: Posttranslational protein translocation across the membrane of the endoplasmic reticulum. Biol Chem 1999;380:1143-1150
33. Turano C, Coppari S, Altieri F, Ferraro A: Proteins of the PDI family: Unpredicted non-ER locations and functions. J Cell Physiol 2002;193:154-163
34. Ryu JW, Kim HJ, Lee YS, Myong NH, Hwang CH, Lee GS, Yom HC: The proteomics approach to find biomarkers in gastric cancer. J Korean Med Sci 2003;18:505-509
35. Tomonaga T, Matsushita K, Yamaguchi S, Oh-Ishi M, Kodera Y, Maeda T, Shimada H, Ochiai T, Nomura F: Identification of altered protein expression and post-translational modifications in primary colorectal cancer by using agarose two-dimensional gel electrophoresis. Clin Cancer Res 2004;10:2007-2014
36. Yano T: The energy-transducing NADH: Quinone oxidoreductase, complex I. Mol Aspects Med 2002;23:345-368
37. Liu X, Wu Y, Zehner ZE, Jackson-Cook C, Ware JL: Proteomic analysis of the tumorigenic human prostate cell line M12 after microcell-mediated transfer of chromosome 19 demonstrates reduction of vimentin. Electrophoresis 2003;24:3445-3453
38. Lebret T, Watson RW, Fitzpatrick JM: Heat shock proteins: Their role in urological tumors. J Urol 2003;169:338-346
39. Noh DY, Ahn SJ, Lee RA, Kim SW, Park IA, Chae HZ: Overexpression of peroxiredoxin in human breast cancer. Anticancer Res 2001;21:2085-2090
40. Kinnula VL, Lehtonen S, Sormunen R, Kaarteenaho-Wiik R, Kang SW, Rhee SG, Soini Y: Overexpression of peroxiredoxins I, II, III, V, and VI in malignant mesothelioma. J Pathol 2002;196:316-323
41. Choi JH, Kim TN, Kim S, Baek SH, Kim JH, Lee SR, Kim JR: Overexpression of mitochondrial thioredoxin reductase and peroxiredoxin III in hepatocellular carcinomas. Anticancer Res 2002;22:3331-3335
42. Linder S, Havelka AM, Ueno T, Shoshan MC: Determining tumor apoptosis and necrosis in patient serum using cytokeratin 18 as a biomarker. Cancer Lett 2004;214:1-9
43. Xie Y, Meier KE: Lysophospholipase D and its role in LPA production. Cell Signal 2004;16:975-981
44. Wang Y, Morrow JS: Identification and characterization of human SLP-2, a novel homologue of stomatin (band 7.2b) present in erythrocytes and other tissues. J Biol Chem 2000; 275:8062-8071
45. Wang MC, Valenzuela LA, Murphy GP, Chu TM: Purification of a human prostate specific antigen. Invest Urol 1979; 17:159-163
46. Barry MJ: Prostate-specific-antigen testing for early diagnosis of prostate cancer. N Engl J Med 2001;344:1373-1377
47. Thompson IM, Pauler DK, Goodman PJ, Tangen CM, Lucia MS, Parnes HL, Minasian LM, Ford LG, Lippman SM, Crawford ED, Crowley JJ, Coltman CA Jr: Prevalence of prostate cancer among men with a prostate-specific antigen level ≤4.0 ng per milliliter. N Engl J Med 2004;350:2239-2246
48. Brawer MK, Chetner MP, Beatie J, Buchner DM, Vessella RL, Lange PH: Screening for prostatic carcinoma with prostate specific antigen. J Urol 1992;147:841-845
49. Stamey TA, Caldwell M, McNeal JE, Nolley R, Hemenez M, Downs J: The prostate specific antigen era in the United States is over for prostate cancer: What happened in the last 20 years? J Urol 2004;172:1297-1301